Twenty-first century progress toward the global control of human hookworm infection.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 21462001)

Published in Curr Infect Dis Rep on June 01, 2011

Authors

Richard Bungiro1, Michael Cappello

Author Affiliations

1: Department of Molecular Microbiology and Immunology, Brown University, Box G-B6, Providence, RI, 02912, USA, Richard_Bungiro@Brown.edu.

Articles by these authors

Disruption of Ixodes scapularis anticoagulation by using RNA interference. Proc Natl Acad Sci U S A (2004) 1.56

Epidemiology of hookworm infection in Kintampo North Municipality, Ghana: patterns of malaria coinfection, anemia, and albendazole treatment failure. Am J Trop Med Hyg (2011) 1.40

Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast. Proc Natl Acad Sci U S A (2010) 1.21

Structural and functional characterization of a secreted hookworm Macrophage Migration Inhibitory Factor (MIF) that interacts with the human MIF receptor CD74. J Biol Chem (2007) 1.14

A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses. J Immunol (2008) 1.09

Isolation and molecular cloning of a secreted hookworm platelet inhibitor from adult Ancylostoma caninum. Mol Biochem Parasitol (2003) 1.06

Role for nitric oxide in hookworm-associated immune suppression. Infect Immun (2008) 1.03

Characterisation of a fatty acid and retinol binding protein orthologue from the hookworm Ancylostoma ceylanicum. Int J Parasitol (2009) 1.01

Orthologs of macrophage migration inhibitory factor from parasitic nematodes. Trends Parasitol (2008) 1.00

Hookworm infection: new developments and prospects for control. Curr Opin Infect Dis (2004) 1.00

Dietary iron content mediates hookworm pathogenesis in vivo. Infect Immun (2006) 0.98

Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis. BMC Immunol (2010) 0.98

Epidemiology and management of infectious diseases in international adoptees. Clin Microbiol Rev (2005) 0.96

Drug repositioning and pharmacophore identification in the discovery of hookworm MIF inhibitors. Chem Biol (2011) 0.96

Molecular characterization of Ancylostoma ceylanicum Kunitz-type serine protease inhibitor: evidence for a role in hookworm-associated growth delay. Infect Immun (2004) 0.96

The promise and pitfalls of mass drug administration to control intestinal helminth infections. Curr Opin Infect Dis (2012) 0.94

Detection of excretory/secretory coproantigens in experimental hookworm infection. Am J Trop Med Hyg (2005) 0.94

Molecular characterization of Ancylostoma inhibitors of coagulation factor Xa. Hookworm anticoagulant activity in vitro predicts parasite bloodfeeding in vivo. J Biol Chem (2001) 0.89

Purification and molecular cloning of and immunization with Ancylostoma ceylanicum excretory-secretory protein 2, an immunoreactive protein produced by adult hookworms. Infect Immun (2004) 0.89

Molecular cloning and characterization of a C-type lectin from Ancylostoma ceylanicum: evidence for a role in hookworm reproductive physiology. Mol Biochem Parasitol (2006) 0.88

Discovery and pre-clinical development of antithrombotics from hematophagous invertebrates. Curr Med Chem Cardiovasc Hematol Agents (2005) 0.87

Poly-helminth Infection in East Guatemalan School Children. J Glob Infect Dis (2011) 0.85

Short report: an agar plate method for culturing hookworm larvae: analysis of growth kinetics and infectivity compared with standard coproculture techniques. Am J Trop Med Hyg (2007) 0.84

Oral transfer of adult Ancylostoma ceylanicum hookworms into permissive and nonpermissive host species. Infect Immun (2003) 0.83

Ancylostoma ceylanicum excretory/secretory protein 1: purification and molecular cloning of a major secretory protein from adult hookworms. Mol Biochem Parasitol (2002) 0.83

Acute pyelonephritis caused by Aerococcus urinae in a 12-year-old boy. Pediatr Infect Dis J (2008) 0.80

In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility. Am J Trop Med Hyg (2013) 0.79

Hookworm infection among school age children in Kintampo north municipality, Ghana: nutritional risk factors and response to albendazole treatment. Am J Trop Med Hyg (2013) 0.78

Ancylostoma ceylanicum excretory-secretory protein 2 adopts a netrin-like fold and defines a novel family of nematode proteins. J Mol Biol (2011) 0.78

Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes. BMC Immunol (2014) 0.77

Cloning and molecular characterization of cDNAs encoding three Ancylostoma ceylanicum secreted proteins. Acta Parasitol (2013) 0.77

Peroxiredoxin-1 from the human hookworm Ancylostoma ceylanicum forms a stable oxidized decamer and is covalently inhibited by conoidin A. Chem Biol (2013) 0.77

Ancylostoma ceylanicum anticoagulant peptide-1: role of the predicted reactive site amino acid in mediating inhibition of coagulation factors Xa and VIIa. Mol Biochem Parasitol (2004) 0.77

A furoxan-amodiaquine hybrid as a potential therapeutic for three parasitic diseases(). Medchemcomm (2012) 0.76

The molecular diagnosis of parasitic diseases. Pediatr Infect Dis J (2008) 0.76

Frequency and intensity of exposure mediate resistance to experimental infection with the hookworm, Ancylostoma ceylanicum. Exp Parasitol (2012) 0.75

Short report: Ancylostoma ceylanicum: exsheathment is not required for successful cryopreservation of third stage hookworm larvae. Am J Trop Med Hyg (2003) 0.75

Ancylostoma ceylanicum metalloprotease 6 DNA vaccination induces partial protection against hookworm challenge infection. Acta Parasitol (2013) 0.75

Anticoagulant peptides from Ancylostoma caninum are immunologically distinct and localize to separate structures within the adult hookworm. Mol Biochem Parasitol (2004) 0.75